NewAmsterdam Pharma Co N.V (NAMS) Debt Ratio: 2022-2025
Historic Debt Ratio for NewAmsterdam Pharma Co N.V (NAMS) over the last 2 years, with Sep 2025 value amounting to 0.06.
- NewAmsterdam Pharma Co N.V's Debt Ratio rose 31.07% to 0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06, marking a year-over-year increase of 31.07%. This contributed to the annual value of 0.04 for FY2024, which is 19.77% up from last year.
- Latest data reveals that NewAmsterdam Pharma Co N.V reported Debt Ratio of 0.06 as of Q3 2025, which was up 119.66% from 0.03 recorded in Q2 2025.
- In the past 5 years, NewAmsterdam Pharma Co N.V's Debt Ratio registered a high of 0.07 during Q1 2024, and its lowest value of 0.01 during Q4 2022.
- In the last 3 years, NewAmsterdam Pharma Co N.V's Debt Ratio had a median value of 0.04 in 2024 and averaged 0.04.
- Its Debt Ratio has fluctuated over the past 5 years, first surged by 317.99% in 2023, then plummeted by 57.53% in 2025.
- Quarterly analysis of 4 years shows NewAmsterdam Pharma Co N.V's Debt Ratio stood at 0.01 in 2022, then skyrocketed by 317.99% to 0.04 in 2023, then climbed by 19.77% to 0.04 in 2024, then surged by 31.07% to 0.06 in 2025.
- Its Debt Ratio was 0.06 in Q3 2025, compared to 0.03 in Q2 2025 and 0.03 in Q1 2025.